Our AI-powered Code-Breakerâ„¢ platform interrogates small RNAs (sRNAs) isoform hotspots that drive heterogenous diseases

CODE-BREAKER CHARACTERIZES THE LANDSCAPE OF FUNCTIONAL sRNA ISOFORMS, MODELS THEIR ROLE IN DISEASE, IDENTIFIES PATIENT SUBSETS, AND DIGITALLY DESIGNS PRECISION DRUGS IN < ONE YEAR

BIOLOGY-INFLUENCED MACHINE LEARNING IDENTIFIES HOTSPOTS WHERE THERE IS HIGH ISOFORM BURDEN SHARED BETWEEN GROUPS OF PATIENTS WITHIN A DISEASE INDICATION

Platform analyzes millions of sRNA features to identify mutations that :

  • Classifies disease
  • Stratifies subjects
  • Predicts disease drivers
  • Designs biomarker-guided precision oligonucleotide therapies

OLIGONUCLEOTIDES TARGETING THE EFFECTS OF DISEASE-DRIVING sRNA ISOFORMS REPRESENT A NEW CLASS OF RNA THERAPEUTICS

sRNA therapeutics are delivered using lipid nanoparticles (LNPs) and conjugates

High fidelity therapeutics targeting sRNA isoforms enable unmatched precision

Advancements in LNP and conjugate chemistry enable drug delivery to specific tissue

SEMANTIC KNOWLEDGE GRAPH DISCOVERS COMMON HOTSPOTS WHERE THERE IS HIGH ISOFORM BURDEN ACROSS DISEASE INDICATIONS

Disease Linkage

Discover novel drugs that treat multiple indications

Repurpose existing compounds including small molecules, protacs, MABs

Introduce new combinational therapies

Next: LEARN MORE ABOUT small RNAs (sRNAs)